雜志介紹

Hpb雜志介紹

《Hpb》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱血紅蛋白，本刊主要出版、報道醫(yī)學-SURGERY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數(shù)為5.6。

本刊近期中國學者發(fā)表的論文主要有：

• Preoperative prediction model of microvascular invasion in patients with hepatocellular carcinoma

  Author: Zhang, Jianfeng; Zeng, Fanxin; Jiang, Shijie; Tang, Hui; Zhang, Jian

• Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China

  Author: Yang, Shun-Chao; Liang, Lei; Wang, Ming-Da; Wang, Xian -Ming; Gu, Li -Hui; Lin, Kong-Ying; Zhou, Ya-Hao; Chen, Ting-Hao; Gu, Wei-Min; Li, Jie; Wang, Hong; Chen, Zhong; Li, Chao; Yao, Lan-Qing; Diao, Yong-Kang; Sun, Li -Yang; Zhang, Cheng-Wu; Zeng, Yong-Yi; Lau, Wan Yee; Huang, Dong-Sheng; Shen, Feng; Yang, Tian

• Beyond successful hemostasis: CT findings and organ failure predict postoperative death in patients suffering from post-pancreatoduodenectomy hemorrhage

  Author: Yang, Jie; Chen, Yonghua; Liu, Xubao; Zheng, Zhenjiang; Wang, Xing; Li, Yichen; Tan, Chunlu

• Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma

  Author: Lima, Henrique A.; Alaimo, Laura; Brown, Zachary J.; Endo, Yutaka; Moazzam, Zorays; Tsilimigras, Diamantis I.; Shaikh, Chanza; Resende, Vivian; Guglielmi, Alfredo; Ratti, Francesca; Aldrighetti, Luca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Hugh, Tom; Endo, Itaru; Shen, Feng; Pawlik, Timothy M.

英文介紹

Hpb雜志英文介紹

HPB is an international forum for clinical, scientific and educational communication.

Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.

Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.

HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.

Abstracted and Indexed in:

MEDLINE?

EMBASE

PubMed

Science Citation Index Expanded

Academic Search (EBSCO)

HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).